Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database

por Best, Jennie H., Kong, Amanda M., Unizony, Sebastian, Tran, Oth, Michalska, Margaret
Publicado 2019

Treatment failure in giant cell arteritis

por Unizony, Sebastian H, Bao, Min, Han, Jian, Luder, Yves, Pavlov, Andrey, Stone, John H
Publicado 2021

Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis

por Matza, Mark A, Dagincourt, Nicholas, Mohan, Shalini V, Pavlov, Andrey, Han, Jian, Stone, John H, Unizony, Sebastian H
Publicado 2023

The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial

por Patel, Naomi J., Fu, Xiaoqing, Zhang, Yuqing, Unizony, Sebastian H., Wallace, Zachary S., Choi, Hyon K., Stone, John H.
Publicado 2021

Design of the Tocilizumab in Giant Cell Arteritis Trial

por Unizony, Sebastian H., Dasgupta, Bhaskar, Fisheleva, Elena, Rowell, Lucy, Schett, Georg, Spiera, Robert, Zwerina, Jochen, Harari, Olivier, Stone, John H.
Publicado 2013

Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis

por Arvikar, Sheila L, Collier, Deborah S, Fisher, Mark C, Unizony, Sebastian, Cohen, George L, McHugh, Gail, Kawai, Toshihisa, Strle, Klemen, Steere, Allen C
Publicado 2013

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis

por Schmidt, Wolfgang A., Dasgupta, Bhaskar, Luqmani, Raashid, Unizony, Sebastian H., Blockmans, Daniel, Lai, Zhihong, Kurrasch, Regina H., Lazic, Ivana, Brown, Kurt, Rao, Ravi
Publicado 2020

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

por Unizony, Sebastian, McCulley, Timothy J., Spiera, Robert, Pei, Jinglan, Sidiropoulos, Paris N., Best, Jennie H., Birchwood, Christine, Pavlov, Andrey, Stone, John H.
Publicado 2021

New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension

por Stone, John H, Spotswood, Helen, Unizony, Sebastian H, Aringer, Martin, Blockmans, Daniel , Brouwer, Elisabeth, Cid, Maria C, Dasgupta, Bhaskar, Rech, Juergen, Salvarani, Carlo, Spiera, Robert, Bao, Min
Publicado 2021

Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

por Stone, John H., Tuckwell, Katie, Dimonaco, Sophie, Klearman, Micki, Aringer, Martin, Blockmans, Daniel, Brouwer, Elisabeth, Cid, Maria C., Dasgupta, Bhaskar, Rech, Juergen, Salvarani, Carlo, Schulze‐Koops, Hendrik, Schett, Georg, Spiera, Robert, Unizony, Sebastian H., Collinson, Neil
Publicado 2019

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

por Cid, Maria C, Unizony, Sebastian H, Blockmans, Daniel, Brouwer, Elisabeth, Dagna, Lorenzo, Dasgupta, Bhaskar, Hellmich, Bernhard, Molloy, Eamonn, Salvarani, Carlo, Trapnell, Bruce C, Warrington, Kenneth J, Wicks, Ian, Samant, Manoj, Zhou, Teresa, Pupim, Lara, Paolini, John F
Publicado 2022

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

por Schmidt, Wolfgang A., Dasgupta, Bhaskar, Sloane, Jennifer, Giannelou, Angeliki, Xu, Yuqing, Unizony, Sebastian H., Mackie, Sarah L., Gonzalez-Gay, Miguel A., Spiera, Robert, Warrington, Kenneth J., Villiger, Peter M., Nivens, Michael C., Akinlade, Bolanle, Lin, Yong, Buttgereit, Frank, Stone, John H.
Publicado 2023

Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated pat...

por Prieto-González, Sergio, Terrades-García, Nekane, Corbera-Bellalta, Marc, Planas-Rigol, Ester, Miyabe, Chie, Alba, Marco A, Ponce, Ariel, Tavera-Bahillo, Itziar, Murgia, Giuseppe, Espígol-Frigolé, Georgina, Marco-Hernández, Javier, Hernández-Rodríguez, José, García-Martínez, Ana, Unizony, Sebastian H, Cid, Maria C
Publicado 2017

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

por Stone, John H., Frigault, Matthew J., Serling-Boyd, Naomi J., Fernandes, Ana D., Harvey, Liam, Foulkes, Andrea S., Horick, Nora K., Healy, Brian C., Shah, Ruta, Bensaci, Ana Maria, Woolley, Ann E., Nikiforow, Sarah, Lin, Nina, Sagar, Manish, Schrager, Harry, Huckins, David S., Axelrod, Matthew, Pincus, Michael D., Fleisher, Jorge, Sacks, Chana A., Dougan, Michael, North, Crystal M., Halvorsen, Yuan-Di, Thurber, Tara K., Dagher, Zeina, Scherer, Allison, Wallwork, Rachel S., Kim, Arthur Y., Schoenfeld, Sara, Sen, Pritha, Neilan, Tomas G., Perugino, Cory A., Unizony, Sebastian H., Collier, Deborah S., Matza, Mark A., Yinh, Janeth M., Bowman, Kathryn A., Meyerowitz, Eric, Zafar, Amna, Drobni, Zsofia D., Bolster, Marcy B., Kohler, Minna, D’Silva, Kristin M., Dau, Jonathan, Lockwood, Megan M., Cubbison, Caroline, Weber, Brittany N., Mansour, Michael K.
Publicado 2020